Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neuronetics Inc (NQ: STIM )

0.9470 -0.0180 (-1.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 298,366
Open 0.9600
Bid (Size) 0.9473 (1)
Ask (Size) 0.9750 (20)
Prev. Close 0.9650
Today's Range 0.9400 - 0.9820
52wk Range 0.6640 - 5.070
Shares Outstanding 30,295,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facility 
From Neuronetics
Via GlobeNewswire
Gold Gains Over 1%; Starbucks Shares Move Higher
Via Benzinga

Performance

YTD
-65.56%
-65.56%
1 Month
-50.16%
-50.16%
3 Month
-54.47%
-54.47%
6 Month
-71.22%
-71.22%
1 Year
-41.54%
-41.54%

More News

Read More
Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations
Via Benzinga
Crude Oil Surges 2%; B. Riley Financial Shares Plunge
Via Benzinga
Exposures Fossil Fuels
STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
From Neuronetics
Via GlobeNewswire
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
From Neuronetics
Via GlobeNewswire
3 Neurotech Stocks Bridging Mind and Machine
Via InvestorPlace
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
From Neuronetics
Via GlobeNewswire
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
From Neuronetics
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
NeuroStar® Launches Better Me Provider Program Nationwide
From Neuronetics
Via GlobeNewswire
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
From Neuronetics
Via GlobeNewswire
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
From Neuronetics
Via GlobeNewswire
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
Via Benzinga
Exposures Fossil Fuels
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
From Neuronetics
Via GlobeNewswire
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
From Neuronetics
Via GlobeNewswire
Top 5 Health Care Stocks That May Plunge In March
Via Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.